|
|
SECOND LATIN AMERICAN
PHARMACEUTICAL AND
MEDICAL DEVICE
COMPLIANCE CONGRESS
AND BEST PRACTICES FORUM
July 29 - 31, 2014
|
ATTEND ONSITE
The Krystal Grand Reforma Uno
Mexico City, Mexico
|
WEBCAST PARTICIPATION
Live and Archived
for 6 Months
|
Plenary session presentations will be in Spanish
and English with simultaneous translation.
|
THE IFPMA CODE WORKSHOP AND ETHICAL
PROMOTION ROUNDTABLE IS SOLD OUT.
|
|
No additional registrations are being taken.
|
|
KEYNOTE SPEAKERS
|
Eduardo Bohorquez
Executive Director, Transparencia Mexicana, Mexico Chapter of Transparency International, Executive Director, The East Country Foundation, Mexico City, Mexico |
Joanna Groves
Chief Executive Officer, International Alliance of Patients' Organizations (IAPO), London, UK |
Otmar Kloiber, MD, PhD
Secretary General, World Medical Association, Ferney-Voltaire, France
|
Alma Rocio Balcazar Romero
Representative, Transparency International, Independent Consultant on Governance, Compliance and Corruption Risks, Bogota, Columbia |
Luis Villalba
Executive Director, The Latin American Federation of Pharmaceutical Industries (FIFARMA), Mexico, D.F., Mexico |
Russell Williams
President, Canada's Research-Based Pharmaceutical Companies (Rx&D), Former Member, National Assembly of Quebec, Ottawa, ON, Canada
|
|
|
|
PHARMA AND DEVICE COMPANY EXECUTIVE KEYNOTE SPEAKERS
|
Óscar Ferenczi
Senior Vice President Latin America, Grunental, Former Head Latin America, Sandoz, Former Vice President & General Manager Brazil, and Former General Manager Chile, Peru, and Ecuado, Merck Sharp & Dohme, Miami, FL, USA |
Antonio Ferreira
International Vice President, Janssen Latin America, part of Janssen Pharmaceutical Companies of Johnson & Johnson, Chairman, Johnson & Johnson Latin American Contribution Committee (LACC), Board Member, Council of the Americas, Miami, FL, USA |
Gavin French
Vice President and General Manager Latin America, Edwards Lifesciences, Sao Paulo, Brazil
|
Carlos D. Garcia, MBA
President, Latin America and Canada, Novartis, Miami, FL |
Miguel Salazar Hernandez
President and Country Manager, Mexico, Central America and Dominican Republic, Boehringer Ingelheim Mexico S.A. de C.V., Mexico City, Mexico |
Martin Mercer
Vice President Latin America, Astellas Pharma, Former President, International Region, Valeant Pharmaceuticals International, Inc., Former Vice President North Andes Zone, GlaxoSmithKline, Northbrook, IL, USA |
|
|
|
LATIN AMERICAN PHARMA ASSOCIATION EXECUTIVE KEYNOTE SPEAKERS
|
Dr. Alfredo Hector Ahuad
Medical Manager, Camara Argentina de Especialidades Medicinales, Buenos Aires, Argentina |
Rafael Gual Cosio, CH.E.
General Director, National Chamber of Pharmaceutical Industry (CANIFARMA), Mexico City, Mexico |
Maria Jose Delgado
General Director, Brazilian Research-based Pharmaceutical Manufacturers Association (InterFarma)
Sao Paulo, Brazil
|
Dr. Francisco de Paula Gomez
Executive President, Association of Pharmaceutical Research Laboratories (AFIDRO), Bogota, D. C. - Colombia |
Dr. Rodolfo Lambour
Executive Director, Central American Federation of Pharmaceutical Laboratories (FEDEFARMA), Guatemala |
Dr. Carlos Campillo Serrano
President, Consejo de Ética y Transparencia de la Industria Farmacéutica (CETIFARMA), Mexico City, Mexico
|
|
|
|
MEXICAN KEYNOTE SPEAKERS
|
Mikel Arriola, MPP, LLM
Head, Federal Commission for the Protection from Sanitary Risks (COFEPRIS), Former Head, Unit for Revenue Legislation, Ministry of Finance and Public Credit, Mexico City, Mexico |
Dr. Dagoberto Cortés
General Director Laboratorios HormonaSanfer, President, National Chamber of Pharmaceutical Industry, Mexico City, Mexico |
Alberto Lifshitz Guinzberg, MD
Head of Clinical Instruction and Medical Internship Medical School, National Autonomous University of Mexico, Mexico City, Mexico
|
Ing. Guillermo Funes Rodríguez
General Director Laboratorios Silanes, Mexico City, Mexico |
Enrique Ruelas, MD, MHCS, MPA
President, National Academy of Medicine, Former Dean, National School of Public Health of Mexico, Former Vice Minister of Health of Mexico and Secretary of the General Health Council of Mexico, Mexico City, Mexico |
Alexis Serlin
General Director, Novartis Mexico, Mexico City, Mexico
|
Juan Francisco Millán Soberanes, MD
General Director of Arbitration, National Commission of Medical Arbitration, Board Member, CETIFARMA, Mexico City, Mexico |
Julio Sotelo, MD
Emeritus Researcher, National Institute, of Neurology and Neurosurgery, Representative of Mexico for Medicine, Organization for Economic Co-operation and Development (OECD), Mexico City, Mexico
|
Carlos Banos Urquijo
General Director, Eli Lilly Mexico, Mexico City, Mexico |
Dr. Emma L. Verástegui
Counselor, National Council of Bioethics of Mexico, Mexico City, Mexico
|
|
|
|
FEATURING IFPMA CODE WORKSHOP AND ETHICAL PROMOTION ROUNDTABLE
|
Sponsored by International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on Monday, July 28, 2014.
|
 |
Tamara Music, Manager, Influenza Vaccines & Code Compliance, IFPMA Geneva, Switzerland (Chair)
|
|
|
A MEXICAN COMPLIANCE ROUNDTABLE
|
|
Sponsored by CETIFARMA and IFPMA on the morning of Tuesday, July 29, 2014.
|
 |
|
|
|
Dr. Carlos Campillo Serrano, President, Council of Ethics and Transparency of Pharmaceutical Industry (CETIFARMA), Mexico City, Mexico (Chair)
|
|
|
THE FOLLOWING SPECIAL SESSIONS
|
|
LATAM Compliance and Ethics - Perspectives from the C-suite
LATAM Pharmaceutical Association Executive Roundtable
HCP and Patient Stakeholder Dialogue
Mexico Regulatory and Compliance Roundtable
How the US Sunshine Act and Global Transparency Trends will Impact LATAM
New Business Models and New Compliance Challenges
The Use of Data Analytics in Compliance
Global Code Update Roundtable
Transforming the Compliance
|
|
AND MINI SUMMITS
|
|
Basic Compliance Training I, II and III
MERCOSUR Region (Argentina, Brazil, Paraguay, Uruguay, Venezuela & Bolivia) Compliance Update
Northern LATAM, Central America & Caribbean Compliance Update
Impact of International Pharma Codes on Congresses
How to Make your Compliance Program Successful
Public Procurement and Tendering Update
Best Practices in Monitoring Compliance of Third Parties
Advanced Issues in Global Transparency, Disclosure and Aggregate Spend
Debunking Analytics: Implication of Data on Compliance Monitoring
Global Anti-Bribery Master Class
Managing the Grey Areas of Compliance
New LATAM Business Models & Related Compliance Challenges
Investigations in Latin America
Embedding Integrity with and beyond Compliance Training
Global/LATAM Fair Market Value Update
Monitoring Activity and the Concept of Line Defense
|
|
FEATURED FACULTY
|
Cecilia Abe, MBA
LATAM Regional Compliance Officer, Sanofi-Aventis, Former Senior Compliance Lead for LATAM, AstraZeneca Pharmaceuticals, Miami, FL, USA |
Sergio Abreu, JD
Regional Compliance Officer - LATAM, Merck KGaA, Montevideo, Uruguay |
Jonathan Edward Adams, JD, MBA
Senior Associate, Baker & McKenzie, Mexico City, Mexico
|
Eunice Alcantara
Compliance and Ethics Director Brazil, Bristol Myers Squibb Co., São Paulo, Brazil |
Maritza Escalante Andrade
Health Care Compliance Officer, Johnson & Johnson, Medical Device & Diagnostic, Mexico City, Mexico |
Taka Ariga, Senior Manager
Ernst & Young LLP, Washington DC
|
Elke Baumann
Global Integrity & Compliance Director, Novartis Pharma AG, Basel, Switzerland |
D. Jeffrey Campbell, Esq.
Principal, Porzio, Bromberg & Newman PC, President and Chief Executive Officer, Porzio Life Sciences, Morristown, NJ, USA |
Vanina Caniza, JD, LLM
Partner, Baker & McKenzie, Buenos Aires, Argentina
|
Anita Cava
Professor, Business Law Department, Director, Business Ethics Program, School of Business Administration, Co-Director, UM Ethics Programs, University of Miami, Miami, FL, USA |
Andrés Cedrón, Esq.
Legal Counsel & Director of Compliance - Americas, Stryker, Miramar, FL, USA |
Michael R. Clarke, Esq.
Vice President, Ethics and Compliance Americas, Actavis, Former Vice President and Compliance Officer, Biomet Spine and Bone Healing Technologies, Former Vice President/Chief Ethics and Compliance Officer, University of Medicine and Dentistry of New Jersey, Morristown, NJ, USA
|
Paul Curtin, Esq.
Executive Director, International Compliance, Forest Laboratories, New York, NY, USA |
Mauro Diaz, MBA
Compliance Officer, Latin America Pharmaceuticals, GlaxoSmithKline, Rio de Janeiro, Brazil |
Gildas Durand
Senior Manager, Ernst & Young LLP, Miami, FL, USA
|
Felipe N. Ferenzini
Public Law, Life Sciences, Compliance and Regulatory, Trench Rossi e Watanabe Advogados, Brasil |
Esther M. Flesch, Esq.
Partner, Trench, Rossi e Watanabe and Baker & McKenzie, São Paulo, Brazil |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel and Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Sandra Gonzalez, Esq.
Associate, Porzio, Bromberg & Newman, Manager of Regulatory and Compliance Services, Porzio Life Sciences, LLC., Morristown, NJ, USA |
Adam Kozielec, CPA
Manager, Corporate Internal Audit, Johnson & Johnson, New York, NY, USA |
Claudia Hernandez Loustalot Laclette, MA
Pharma and Country Compliance Head Mexico, Novartis Corporativo, S.A. de C.V., Former Compliance and Ethics Director, Bristol-Myers Squibb, Former Compliance Manager, Eli Lilly, Mexico, City, Mexico
|
Cesar Lara
Director, Pharmaceutical and Life Sciences Advisory, PwC, Mexico City, Mexico |
Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC, USA |
Rodrigo Salles Medina, JD, LLM
Legal Director - Latin America | Medtronic Inc., Miami, FL, USA
|
Maritza I. Munich, Esq.
Chief Legal Officer, General Counsel & Corporate Secretary, Medical Card System, Inc., Former General Counsel, Mexico & Central America, The Procter & Gamble Company, Former Vice President & General Counsel - International, Wal-Mart Stores, Inc., San Juan, Puerto Rico, USA |
Ryan D. Murphy
Partner, Pharmaceutical and Life Sciences Forensics, PwC, Chicago, IL, USA |
Chrisoula Nikidis
Director, Ethics and Compliance, Canada's Research-Based Pharmaceutical Companies (Rx&D), Ottawa, ON, Canada
|
Jan Oliver Huber
General Secretary, Austrian Pharmaceutical Industry Association (PHARMIG), Member, IFPMA Code Compliance Network, Vienna, Austria |
Fernando M. Caleiro Palma, Esq.
Diretor Executivo, Corporate Compliance, Assurance - FIDS, Ernst & Young, Executive, Instituto dos Advogados de São Paulo (IASP) and Fundação Instituto de Administração, Business School (FIA), São Paulo, Brazil |
SanDee Priser, JD, CPA
Partner, EY, New York, NY
|
Louis Ramos, Esq.
Lead Compliance Counsel for Latin America, International R&D and Manufacturing, Pfizer Inc.; Former Assistant United States Attorney, United States Attorney's Office for the District of Columbia, Washington, DC, USA |
Brian Riewerts
Principal, Global Governance, Risk and Compliance Leader, Pharmaceutical and Life Sciences Advisory, PwC, Baltimore, MD, USA |
Jeffrey Rosenbaum, MBA
Senior Vice President and Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance, Novartis Oncology, Boston, MA, USA
|
Christian-Claus Roth
Head of Congresses and Conventions, Novartis Pharma, Co-President, International Pharmaceutical Congress Advisory Association (IPCAA), Berne, Switzerland |
Ilana Shulman, Esq.
Associate General Counsel, Legal and Compliance, Astellas US LLC, Northbrook, IL, USA |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK
|
Robert Skinner
Deputy Compliance Officer, Emerging Markets, Asia Pacific and Japan, GlaxoSmithKline, Chalfont St. Giles, Buckinghamshire, UK |
David Stainback
Director Pharmaceutical and Life Sciences Advisory, PwC, Atlanta, GA, USA |
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA
|
Trevor Wear, MHA, JD
Partner, Sidley Austin LLP, Chicago, IL |
Fatima Wolff, Esq.
Senior Compliance Counsel, Boston Scientific Corporation, Miami, FL, USA |
David Wysocky
Principal, Pharmaceutical and Life Sciences Advisory, PwC, Florham Park, NJ, USA
|
|
|
SECOND LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
AND BEST PRACTICES FORUM
|
ATTEND ONSITE
July 29 - 31, 2014
The Krystal Grand Reforma Uno
Mexico City, Mexico
|
OR |
WEBCAST PARTICIPATION
In your own office or home live via the Internet with 24/7 access for six months
|
 |
|
|
|
2016 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
TENTH INTERNATIONAL PHARMACEUTICAL
COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 10 - 12, 2016
Hilton Warsaw Hotel and Convention Centre
Warsaw, Poland
www.InternationalPharmaCongress.com
|
|
SIXTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 2016
Singapore
www.AsianPharmaCongress.com
|
|
SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
BROCHURE NOW AVAILABLE
|
Click Here to download
the brochure.
Click Here to download
IFPMA Code Workshop Flyer.
|
|
|
|
ASSOCIATION REGISTRATION DISCOUNTS
|
|
Click here for Special LatAm E&CN/CETIFARMA/ CANIFARMA/ETHICS/ PCF/IFPMA Member Rate.
|
|
|
|
|
SPONSORED BY
|
|
|
|
CO CHAIRS
|
Imelda Álvarez
Integrity and Compliance Head for Latin America and Canada, Novartis Corporativo, S.A. de C.V., Mexico City, Mexico
|
Felipe Coronel, Esq.
Chief Compliance Officer, Regional Head Office, Grünenthal Latin America, Panama City, Panama
|
Karla Guillén
Regional Lead Officer - Pharma Latin America, Health Care Compliance & Privacy, Johnson & Johnson, Mexico City, Mexico
|
CO SPONSORED BY
|
|
|
CONTINUING EDUCATION CREDITS
|
Accounting Professionals: Approved for up to 17.0 NASBE CPE credits.
Compliance Professionals: Approved for up to 19.6 Compliance Certification Board CCB Credits.
Attorneys:
Approved to offer a maximum of 16.00 Hours of California CLE Credits.
Approved to offer a maximum of 15.00 Hours of Pennsylvania CLE Credits.
Approved to offer a maximum of 16.00 Hours of Texas CLE Credits.
Click here for more information.
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
GOLD
|
|
|
BRONZE
|
|
|
MEDIA PARTNER
|
|
|
OTHER INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
2011 - Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
2013 - Madrid, Spain
2013 - Kuala Lumpur, Malaysia
2014 - Dubai, United Arab Emirates
2014 - Mexico City, Mexico
2014 - Shanghai, China
|
|
|
FOLLOW LATIN AMERICAN PHARMA CONGRESS ON
|
|
|
PARTICIPATION OPTIONS
|
|
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
|
|
|
|
